ARKG Holdings of CRISPR Therapeutics (CRSP) - Updated Daily
TherapeuticsGene TherapyCAR-T Cell TherapyCRSPR Gene Editing
Key Statistics
Statistics
⚖️Weighting | 🧢Market Cap |
---|---|
7.43% | $3.82b |
🏋🏿♂️Weight Rank In ARKG | 🌏Country |
1 | 🇨🇭Switzerland |
🏋️♀️Weight Rank Across All Funds | 💳ARK Estimated Cost Average |
208 | $70.01 |
🎫ARK Ownership Percent | |
2.14% |
Other ETFs That Hold CRSP
Research Notes and Commentary for CRSP
No Research Notes Found for CRSP